Velpatasvir (Anti-HCV Drug) Key Intermediate (Core Use) Critical building block for synthesizing Velpatasvir, a direct-acting antiviral agent against hepatitis C virus (HCV). It undergoes cyclization, substitution, and coupling reactions to construct the core dibenzochromenone scaffold of Velpatasvir, ensuring high potency and broad genotype coverage for HCV treatment.

Antiviral Pharmaceutical Intermediate Used in the synthesis of other antiviral drugs targeting RNA viruses (e.g., HCV, dengue, Zika); the dibenzochromenone core enhances binding to viral non-structural proteins (NS5A/NS5B).

Heterocyclic Chemistry Building Block Serves as a precursor for complex fused-ring systems via nucleophilic substitution (bromo groups) and carbonyl condensation; widely applied in synthetic methodology for polycyclic aromatic compounds.

Laboratory Research & Reference Standard Employed in pharmaceutical R&D, impurity profiling, and as a reference standard for HPLC analysis in antiviral drug development.